ACCESS Newswire

    / Wellgistics Health, Inc. (“Wellgistics” or the “Company”) (NASDAQ:WGRX) today announced that it has entered into a non-exclusive, non-binding Letter of Intent (“LOI”) to evaluate a potential acquisition of Neuritek Therapeutics, a neuroscience-focused research organization.

    Latest News

    The Apple iPhone Duo redefines the book-style foldable category by adopting a practical “passport” aspect ratio (5.4-inch outer display, 7.6-inch inner display), a crease-mitigating nano-texture matte finish, and a vapor-cooled 2nm A20 Pro chip. It foregoes Face ID in favor